Patient's Knowledge on Their Anticoagulating and Anti Platelet Treatment St Joseph's Hospital)

F

Fondation Hôpital Saint-Joseph

Status

Completed

Conditions

Coagulation Disorder

Treatments

Other: questionnaire via smartphone

Study type

Interventional

Funder types

Other

Identifiers

NCT03304977
CACHACA

Details and patient eligibility

About

Oral antigoagulant are used more than 60 years in thrombotic diseases. Even they are indispensable, the haemorragic risk is high.That's why it's the main reason of hospitalization for iatrogeny.The complication's reasons are mainly linked to errors of drug intake, drugs interaction and the lack of understanding the treatment.Moreover, the antiplatelet agglutening treatment is frequently added to anticoagulant treatment.This increases the haemorragic risk.Different means were used to minimize the risk , like INR follow up. The purpose of the study is to evaluate smartphone use to follow the patients'treatment.

Full description

Two questionnaire via smartphone with 15 days gap.

Enrollment

100 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • patient under ant-thrombotic treatment
  • hospitalized in vascular medecine service

Exclusion criteria

refusing the participation

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location

Resources

© Copyright 2024 Veeva Systems